Extension of Reporting Deadline

RNS Number : 4968E
Barkby Group PLC (The)
06 November 2020
 

The Barkby Group PLC

("Barkby", the "Group" or the "Company")

Extension of Reporting Deadline

The Barkby Group PLC, the diversified business group, announces that further to the guidance provided by AIM Regulation in "Inside AIM" on 26 March 2020, the Company has been granted an extension of up to three months for the reporting and filing of its financial results for the year ended 30 September 2020 ("FY-2020"). As agreed with AIM Regulation, the Company will therefore publish its FY-2020 results by 31 March 2021. The Company has also applied to and been granted an extension by Companies House to delay the filing of its FY-2020 audited annual accounts until 31 March 2021.

 

 

Enquiries: 

 

The Barkby Group PLC


Charles Dickson, Executive Chairman

Douglas Benzie, Chief Financial Officer






finnCap Ltd (Nomad and Broker)

+44 (0) 20 7220 0500

Carl Holmes/Simon Hicks (corporate finance)

Tim Redfern/Richard Chambers (ECM)






Camarco (Financial PR)

+44 (0) 20 3757 4994

Jennifer Renwick/Jake Thomas

 

Notes to editors

 

The Barkby Group PLC is a diversified group of high growth, high quality businesses run by an entrepreneurial and experienced management team. The existing wholly owned businesses within Barkby include; Commercial Property Development, Barkby Hospitality (comprising Barkby Pubs and Workshop Coffee) and Centurian Automotive.

 

In addition to these businesses, Barkby Life Sciences has invested in VivoPlex, a digital health company aiming to transform Women's Health with precision medicine, and its subsidiary Cambridge Sleep Sciences Ltd has launched, SleepHub™, a device which improves and facilitates natural sleep.

 

Barkby's strategy is to accelerate and maximise opportunities within its existing businesses as well as continue to source and invest in cash generative, growth businesses with the ability to disrupt.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCGZMGMNVMGGZG
UK 100

Latest directors dealings